Baylor, Scott and White

Dallas, Texas 75246

6 studies enrolling now · 13 studies all time

What they study most

Acute Decompensated Heart Failure, Acute Kidney Injury Due to Sepsis, Alport Syndrome, Coronary Artery Disease, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Focal Segmental Glomerulosclerosis, Glioblastoma, Heart Transplant, IgA Nephropathy, Immunoglobulin A Nephropathy, Mitral Valve Regurgitation

Studies at this site

• NEO100 and High-Grade Meningioma — Recruiting now
• Enhancing Heart Allograft Function With the OCS Heart System Trial — Recruiting now
• Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) — Recruiting now
• US National OCS Heart Perfusion (OHP) Registry — Recruiting now
• REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities — Recruiting now
• REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women — Recruiting now
• Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI) — Completed
• ABTECT - Maintenance — Running, not enrolling
• Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY) — Running, not enrolling
• Atrasentan in Patients With Proteinuric Glomerular Diseases — Running, not enrolling
• OCS Heart Perfusion Post-Approval Registry — Running, not enrolling
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
• A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy — Completed